MiroBio’s $97 Million Series B Financing

Wilson Sonsini Goodrich & Rosati and Goodwin advised MiroBio on the deal.MiroBio, a leader in the development of checkpoint agonists to treat autoimmune diseases, announced the…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Martina Bellini

Author: Martina Bellini

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here